Display options
Share it on

Vaccines (Basel). 2014 Apr 14;2(2):297-322. doi: 10.3390/vaccines2020297.

Vaccine Potentiation by Combination Adjuvants.

Vaccines

Benoît Levast, Sunita Awate, Lorne Babiuk, George Mutwiri, Volker Gerdts, Sylvia van Drunen Littel-van den Hurk

Affiliations

  1. VIDO-Intervac, University of Saskatchewan, 120 Veterinary Road, Saskatoon, SK S7N 5E3, Canada. [email protected].
  2. VIDO-Intervac, University of Saskatchewan, 120 Veterinary Road, Saskatoon, SK S7N 5E3, Canada. [email protected].
  3. University Hall, University of Alberta, Edmonton, AB T6G 2J9, Canada. [email protected].
  4. VIDO-Intervac, University of Saskatchewan, 120 Veterinary Road, Saskatoon, SK S7N 5E3, Canada. [email protected].
  5. School of Public Health, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada. [email protected].
  6. VIDO-Intervac, University of Saskatchewan, 120 Veterinary Road, Saskatoon, SK S7N 5E3, Canada. [email protected].
  7. Veterinary Microbiology, University of Saskatchewan, 52 Campus Drive, Saskatoon, SK S7N 5B4, Canada. [email protected].
  8. VIDO-Intervac, University of Saskatchewan, 120 Veterinary Road, Saskatoon, SK S7N 5E3, Canada. [email protected].
  9. Microbiology and Immunology, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada. [email protected].

PMID: 26344621 PMCID: PMC4494260 DOI: 10.3390/vaccines2020297

Abstract

Adjuvants are crucial components of vaccines. They significantly improve vaccine efficacy by modulating, enhancing, or extending the immune response and at the same time reducing the amount of antigen needed. In contrast to previously licensed adjuvants, current successful adjuvant formulations often consist of several molecules, that when combined, act synergistically by activating a variety of immune mechanisms. These "combination adjuvants" are already registered with several vaccines, both in humans and animals, and novel combination adjuvants are in the pipeline. With improved knowledge of the type of immune responses needed to successfully induce disease protection by vaccination, combination adjuvants are particularly suited to not only enhance, but also direct the immune responses desired to be either Th1-, Th2- or Th17-biased. Indeed, in view of the variety of disease and population targets for vaccine development, a panel of adjuvants will be needed to address different disease targets and populations. Here, we will review well-known and new combination adjuvants already licensed or currently in development-including ISCOMs, liposomes, Adjuvant Systems Montanides, and triple adjuvant combinations-and summarize their performance in preclinical and clinical trials. Several of these combination adjuvants are promising having promoted improved and balanced immune responses.

Keywords: adjuvants; combinations; human clinical trials; review

References

  1. Mol Pharm. 2011 Feb 7;8(1):153-61 - PubMed
  2. Vaccine. 2008 Jun 25;26(27-28):3461-8 - PubMed
  3. Cancer Res. 2002 Mar 1;62(5):1477-80 - PubMed
  4. N Engl J Med. 2012 Jan 5;366(1):34-43 - PubMed
  5. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1413-8 - PubMed
  6. Vaccine. 2004 Sep 3;22(25-26):3274-84 - PubMed
  7. Pediatr Infect Dis J. 2010 Jun;29(6):e35-46 - PubMed
  8. Lancet. 2001 Dec 8;358(9297):1927-34 - PubMed
  9. PLoS One. 2009 Jun 03;4(6):e5771 - PubMed
  10. Hum Vaccin. 2009 Mar;5(3):151-7 - PubMed
  11. Vaccine. 2008 Jan 24;26(4):552-61 - PubMed
  12. Antiviral Res. 2009 Jan;81(1):37-46 - PubMed
  13. Vaccine. 2013 Jun 28;31(31):3148-55 - PubMed
  14. J Immunol. 1992 Apr 15;148(8):2357-62 - PubMed
  15. Nature. 1997 Mar 27;386(6623):336-7 - PubMed
  16. J Infect Dis. 2009 Aug 1;200(3):337-46 - PubMed
  17. Cancer Immunol Immunother. 2011 Feb;60(2):161-71 - PubMed
  18. Nat Immunol. 2014 Feb;15(2):195-204 - PubMed
  19. Expert Rev Vaccines. 2012 Mar;11(3):349-66 - PubMed
  20. Biochim Biophys Acta. 2005 Dec 10;1718(1-2):22-31 - PubMed
  21. Vaccine. 2011 May 23;29(23):3951-61 - PubMed
  22. Hum Vaccin. 2010 Jul;6(7):578-84 - PubMed
  23. Curr Drug Deliv. 2010 Jan;7(1):13-20 - PubMed
  24. Vaccine. 2011 Mar 16;29(13):2461-73 - PubMed
  25. J Infect Dis. 2005 Dec 15;192(12):2117-23 - PubMed
  26. J Immunol. 2009 Feb 1;182(3):1253-9 - PubMed
  27. PLoS One. 2011 Apr 27;6(4):e18891 - PubMed
  28. Hum Vaccin Immunother. 2012 Mar;8(3):390-7 - PubMed
  29. J Pharm Sci. 2002 Nov;91(11):2283-300 - PubMed
  30. Vaccine. 2011 Oct 13;29(44):7718-26 - PubMed
  31. Vaccine. 2010 Apr 30;28(20):3571-81 - PubMed
  32. Pharm Res. 2009 Jun;26(6):1477-85 - PubMed
  33. Biochimie. 2012 Apr;94(4):1048-56 - PubMed
  34. Immunology. 2010 Jan;129(1):75-86 - PubMed
  35. Cell Microbiol. 2004 Jan;6(1):23-32 - PubMed
  36. Health Technol Assess. 2010 Oct;14 (46):1-130 - PubMed
  37. Vaccine. 2012 Jun 19;30(29):4361-8 - PubMed
  38. ACS Chem Biol. 2009 Jan 16;4(1):65-74 - PubMed
  39. Clin Infect Dis. 2011 Feb 15;52(4):522-31 - PubMed
  40. Expert Rev Vaccines. 2011 Apr;10(4):401-3 - PubMed
  41. J Immunol. 2009 Nov 15;183(10):6186-97 - PubMed
  42. Vaccine. 2006 Oct 30;24(42-43):6483-92 - PubMed
  43. Lancet. 2005 Dec 10;366(9502):2012-8 - PubMed
  44. Vaccine. 2007 Jan 26;25(7):1204-13 - PubMed
  45. Vaccine. 2004 Sep 28;22(29-30):3831-40 - PubMed
  46. Clin Infect Dis. 2010 Sep 15;51(6):668-77 - PubMed
  47. Vaccine. 2011 Feb 1;29(6):1159-66 - PubMed
  48. Vaccine. 2010 Aug 16;28(36):5924-9 - PubMed
  49. Vaccine. 2011 Mar 3;29(11):2100-9 - PubMed
  50. J Immunol. 2005 Mar 1;174(5):3080-6 - PubMed
  51. Int J Cancer. 2011 Feb 15;128(4):897-907 - PubMed
  52. Cancer Immunol Immunother. 2005 Mar;54(3):208-18 - PubMed
  53. J Infect Dis. 2013 Jun 1;207(11):1753-63 - PubMed
  54. Rev Inst Med Trop Sao Paulo. 1970 Jan-Feb;12(1):46-54 - PubMed
  55. Vaccine. 2009 Jul 23;27(34):4662-71 - PubMed
  56. Vaccine. 2011 Jan 10;29(3):426-36 - PubMed
  57. Clin Microbiol Rev. 2006 Jul;19(3):491-511 - PubMed
  58. Reprod Toxicol. 2011 Jan;31(1):111-20 - PubMed
  59. Vaccine. 2006 Jun 29;24(26):5461-72 - PubMed
  60. Vaccine. 2009 Jun 12;27(29):3811-20 - PubMed
  61. Vaccine. 2005 Sep 30;23(41):4935-43 - PubMed
  62. Clin Vaccine Immunol. 2010 Nov;17(11):1763-71 - PubMed
  63. N Engl J Med. 1997 Jan 9;336(2):86-91 - PubMed
  64. Hum Vaccin Immunother. 2012 Apr;8(4):486-90 - PubMed
  65. Kidney Int. 2008 Apr;73(7):856-62 - PubMed
  66. Lancet. 1973 Feb 3;1(7797):215-9 - PubMed
  67. Vaccine. 2002 Oct 4;20(29-30):3498-508 - PubMed
  68. Expert Rev Vaccines. 2011 Feb;10(2):227-51 - PubMed
  69. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3256-61 - PubMed
  70. Hum Vaccin. 2010 Dec;6(12):1054-61 - PubMed
  71. J Gen Virol. 2009 Aug;90(Pt 8):1892-905 - PubMed
  72. Vaccine. 2011 Feb 11;29(8):1595-604 - PubMed
  73. Vaccine. 2012 Jan 11;30(3):589-96 - PubMed
  74. Vaccine. 2012 Jul 27;30(35):5206-14 - PubMed
  75. Vaccine. 2012 Jan 5;30(2):307-16 - PubMed
  76. Hum Vaccin. 2006 Sep-Oct;2(5):222-6 - PubMed
  77. Clin Genet. 2009 Jan;75(1):19-29 - PubMed
  78. PLoS One. 2008;3(11):e3683 - PubMed
  79. Eur J Immunol. 2012 Nov;42(11):3049-61 - PubMed
  80. Vaccine. 2010 Dec 6;28(52):8306-14 - PubMed
  81. Immunology. 2008 Jun;124(2):175-85 - PubMed
  82. Int J Cancer. 2010 Feb 15;126(4):909-18 - PubMed
  83. Immunology. 1966 Oct;11(4):369-86 - PubMed
  84. J Clin Immunol. 2011 Jun;31(3):443-54 - PubMed
  85. Annu Rev Nutr. 2007;27:347-62 - PubMed
  86. Expert Rev Vaccines. 2011 Apr;10(4):471-86 - PubMed
  87. Infect Immun. 2007 May;75(5):2283-90 - PubMed
  88. J Immunol. 2006 Jun 15;176(12):7335-45 - PubMed
  89. Vaccine. 2008 Jun 19;26(26):3209-22 - PubMed
  90. AIDS Res Hum Retroviruses. 2013 Nov;29(11):1504-12 - PubMed
  91. Biochemistry. 1995 Oct 17;34(41):13537-44 - PubMed
  92. PLoS One. 2009 Jun 16;4(6):e5930 - PubMed
  93. J Drug Deliv. 2011;2011:181646 - PubMed
  94. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1650-5 - PubMed
  95. J Immunol. 2004 Sep 1;173(5):3310-9 - PubMed
  96. J Adolesc Health. 2012 Jan;50(1):38-46 - PubMed
  97. Expert Rev Vaccines. 2012 May;11(5):561-77 - PubMed
  98. Med Res Rev. 2002 May;22(3):225-50 - PubMed
  99. Vaccine. 2012 Oct 12;30(46):6595-9 - PubMed
  100. J Immunother. 2004 Mar-Apr;27(2):124-35 - PubMed
  101. Annu Rev Immunol. 1991;9:271-96 - PubMed
  102. Vaccine. 2009 Mar 23;27(14):2048-54 - PubMed
  103. Vaccine. 1997 Jun;15(9):1001-7 - PubMed
  104. Chem Biol. 2010 Sep 24;17(9):970-80 - PubMed
  105. Vaccine. 2009 Dec 9;27(52):7428-35 - PubMed
  106. J Nanobiotechnology. 2011 Sep 02;9:35 - PubMed
  107. Clin Cancer Res. 2012 Dec 1;18(23 ):6497-508 - PubMed
  108. Expert Rev Vaccines. 2011 Apr;10(4):513-21 - PubMed
  109. N Engl J Med. 2002 Nov 21;347(21):1652-61 - PubMed
  110. Can J Vet Res. 1996 Jan;60(1):55-8 - PubMed
  111. Lancet Oncol. 2012 Jan;13(1):100-10 - PubMed
  112. Vaccine. 2010 May 7;28(21):3748-53 - PubMed
  113. Nat Med. 2013 Dec;19(12):1597-608 - PubMed
  114. Am J Clin Oncol. 2006 Aug;29(4):352-60 - PubMed
  115. Expert Rev Vaccines. 2007 Oct;6(5):741-6 - PubMed
  116. Am J Physiol. 1997 Jul;273(1 Pt 2):H387-404 - PubMed
  117. J Clin Invest. 2012 Jan;122(1):303-14 - PubMed
  118. Microbiol Immunol. 1999;43(8):765-71 - PubMed
  119. Antiviral Res. 2008 Jul;79(1):71-9 - PubMed
  120. Vaccine. 2010 Mar 8;28(11):2311-7 - PubMed
  121. PLoS One. 2012;7(3):e34255 - PubMed
  122. Vaccine. 2009 Jul 16;27(33):4424-33 - PubMed
  123. Expert Rev Vaccines. 2003 Apr;2(2):231-8 - PubMed
  124. Vaccine. 2013 Apr 19;31(17):2196-206 - PubMed
  125. Vaccine. 2005 Apr 15;23(21):2740-50 - PubMed
  126. J Gen Virol. 2014 Feb;95(Pt 2):301-6 - PubMed
  127. Vaccine. 2009 Mar 23;27(14):2055-64 - PubMed

Publication Types